Stay updated on Cabozantinib Reverses Carfilzomib Resistance in Myeloma Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib Reverses Carfilzomib Resistance in Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib Reverses Carfilzomib Resistance in Myeloma Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    A unified Locations section now lists Nebraska and Texas as study sites. The separate Nebraska Locations and Texas Locations sections were removed, the HHS Vulnerability Disclosure link was removed, and the page revision advanced to v3.3.3.
    Difference
    0.3%
    Check dated 2025-12-23T09:58:40.000Z thumbnail image
  4. Check
    26 days ago
    No Change Detected
  5. Check
    40 days ago
    Change Detected
    Summary
    Revision updated to v3.3.2 (replacing v3.3.1). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-01T18:14:36.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    Page revision updated from v3.2.0 to v3.3.1. No study content or data appears to be changed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T15:00:12.000Z thumbnail image
  7. Check
    55 days ago
    Change Detected
    Summary
    The notice regarding a lapse in government funding and potential data updates has been removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-17T07:38:47.000Z thumbnail image
  8. Check
    69 days ago
    Change Detected
    Summary
    No significant changes detected in core content; only cosmetic formatting changes were observed on the Study Details page, and there are no updates to inclusion criteria, primary outcomes, or enrollment. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T01:27:12.000Z thumbnail image
  9. Check
    98 days ago
    Change Detected
    Summary
    The page now includes an operating-status notice and a version update to v3.2.0, while removing the previous v3.1.0 reference.
    Difference
    2%
    Check dated 2025-10-05T10:31:00.000Z thumbnail image

Stay in the know with updates to Cabozantinib Reverses Carfilzomib Resistance in Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib Reverses Carfilzomib Resistance in Myeloma Clinical Trial page.